Sumitomo Mitsui Trust Group
PCVX icon

Sumitomo Mitsui Trust Group’s Vaxcyte PCVX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Sell
7,304
-27
-0.4% -$1.47K ﹤0.01% 997
2026
Q1 		$426K Sell
7,331
-953
-12% -$51.7K ﹤0.01% 950
2025
Q4 		$382K Sell
8,284
-62
-0.7% -$2.77K ﹤0.01% 985
2025
Q3 		$301K Buy
+8,346
New +$277K ﹤0.01% 1014
2025
Q1 		– Sell
-5,363
Closed -$439K – 1057
2024
Q4 		$439K Sell
5,363
-286
-5% -$28.4K ﹤0.01% 967
2024
Q3 		$646K Buy
5,649
+1,120
+25% +$101K ﹤0.01% 938
2024
Q2 		$342K Buy
+4,529
New +$308K ﹤0.01% 1000

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group's PCVX Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Vaxcyte (PCVX) stake by 0.37% in Q2 2026, selling an estimated $1.47K and leaving 7,304 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Sumitomo Mitsui Trust Group first reported a position in PCVX in Q2 2024 and has held it in 7 quarters since. The position peaked at $646K in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 7,304 shares of Vaxcyte worth $425K as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 27 Vaxcyte shares in Q2 2026, an estimated $1.47K.
  • Vaxcyte made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #997 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Vaxcyte in Q2 2024 and has held it in 7 quarters since.
  • Sumitomo Mitsui Trust Group's Vaxcyte position peaked at $646K in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.